Medpace (NASDAQ: MEDP) director lines up 7,283-share Rule 144 sale

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) is the issuer for a proposed Rule 144 sale by director Fred B. Davenport Jr.. The notice covers the potential sale of 7,283 shares of Medpace common stock through Fidelity Brokerage Services LLC, in connection with a stock option exercise dated 08/19/2026, with the shares listed on NASDAQ.

Key Figures

Shares to be sold: 7,283 shares Transaction date: 08/19/2026

2 metrics

Shares to be sold 7,283 shares Common stock covered by the Rule 144 notice for director Fred B. Davenport Jr.

Transaction date 08/19/2026 Date associated with the stock option exercise and proposed sale of 7,283 shares

Key Terms

Rule 144, stock option exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 08/19/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as attorney-in-fact for Fred Davenport Jr"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing for MEDP disclose about planned share sales?

The Form 144 notice discloses a proposed sale of 7,283 shares of Medpace Holdings, Inc. (MEDP) common stock. The transaction is tied to a stock option exercise and would be executed through Fidelity Brokerage Services LLC under Rule 144.

Who is selling Medpace (MEDP) shares under this Form 144?

The planned Rule 144 sale involves shares held for the account of Fred B. Davenport Jr., a director of Medpace Holdings, Inc. The filing notes that Fidelity Brokerage Services LLC is acting, with a representative signing as attorney-in-fact for Davenport.

How many Medpace (MEDP) shares are planned to be sold under Rule 144?

The notice covers a potential sale of 7,283 shares of Medpace common stock. This amount appears both in the Securities Information section and in the Securities To Be Sold section of the Rule 144 filing.

What type of transaction is tied to the Medpace (MEDP) Form 144 sale?

The proposed sale of 7,283 shares of Medpace common stock is associated with a Stock Option Exercise. The filing indicates the transaction involves common stock of the issuer and identifies the consideration as Cash on 08/19/2026.

On which market are the Medpace (MEDP) shares in this Form 144 listed?

The common shares referenced in the Form 144 filing are listed on NASDAQ. The filing specifies that the 7,283 shares of Medpace Holdings, Inc. common stock to be sold under Rule 144 trade on this market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 02:46 PM Accepted by SEC EDGAR 08/19/2026 - 02:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001181154
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	DAVENPORT FRED B JR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7283	4414616.10	27911655	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Stock Option Exercise	Issuer			7283	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Corey Walter, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Fred Davenport Jr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)